Skip to content

Diabetes Education and A1c Study

Diabetes Education and A1c Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04806685
Acronym
DEA1c
Enrollment
22
Registered
2021-03-19
Start date
2021-03-15
Completion date
2022-10-01
Last updated
2022-12-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus, Type 2, Sleep

Brief summary

Sleep problems are associated with poor blood glucose control, but current diabetes self-management programs do not include sleep education. This study will randomize participants into two groups: one that receives sleep education and one that does not. The researchers expect both groups to experience reductions in blood glucose. The researchers hypothesize that individuals who receive sleep education as part of their diabetes self-management training will experience greater improvements in blood glucose control, as measured by hemoglobin A1c, compared to the control group.

Interventions

BEHAVIORALSleep education

Medical nutrition therapy plus behavior-based sleep education intervention

BEHAVIORALDiet only

No sleep education

Sponsors

Blue Cross Blue Shield Foundation of Michigan
CollaboratorUNKNOWN
Michigan State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals with a diagnosis of type 2 diabetes who are patients at the Michigan State University (MSU) Endocrinology clinic, * a diagnosis of overweight or obesity (Body Mass Index greater than or equal to 25.0 kg/m2), * the most recent hemoglobin A1c value greater than or equal to 7.5%, and * the ability to attend online program sessions.

Exclusion criteria

* significant psychiatric disorders, * advanced medical conditions that require alterations to the MNT for DM2, e.g., advanced chronic kidney disease, and * an inability to follow recommendations due to cognitive deficits.

Design outcomes

Primary

MeasureTime frameDescription
Hemoglobin A1c12 weeksLab value

Secondary

MeasureTime frameDescription
Sleep duration12 weeksFitBit outcomes data
Sleep quality12 weeksPittsburgh Sleep Quality Index
Body mass index12 weeksCalculated from height and weight
Epworth Sleepiness Scale12 weeksValidated survey measuring excessive daytime sleepiness
Insomnia Severity Index12 weeksValidated survey measuring insomnia symptoms
Diabetes self-care12 weeksDiabetes Self-Management Questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026